All In Biotech

Free tool

FAERS Monitor: Duraclon

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 21, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020615 or its brand name (Duraclon, Clonidine Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

5,684

Serious

3,889

68% of reports

Hospitalization

1,617

Death reported

937

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • hypertension762
  • headache711
  • off label use658
  • pain640
  • fatigue634
  • hypersensitivity549
  • drug ineffective524
  • nausea476
  • infusion related reaction442
  • hepatic enzyme increased436
  • joint swelling426
  • rash411
  • dyspnoea387
  • prescribed overdose374
  • diarrhoea369

Reports by year received

View as table
YearReports
20042
20056
200613
200711
200830
200916
201066
2011115
2012102
201367
201472
2015110
2016117
2017244
2018236
2019222
2020261
2021329
2022618
2023649
2024894
2025895
2026608

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,048,475 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
prescribed overdoseSignal37472.966.025,965
infusion related reactionSignal44224.822.710,051
hepatic enzyme increasedSignal43623.821.89,475
hypertensionSignal76213.412.58,756
joint swellingSignal42613.112.04,760
hypersensitivitySignal54911.010.14,996
headacheSignal7114.23.91,781
painSignal6403.93.61,392
rashSignal4113.53.2743
fatigueSignal6343.02.8884
off label useSignal6582.82.6781
dyspnoeaSignal3872.52.3366
nauseaSignal4762.22.0333
diarrhoeaSignal3692.11.9223
drug ineffective5241.51.484

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.